Introduction The management of type 2 diabetes (T2D) continues to evolve with the introduction of innovative therapies aimed at improving glycemic control, promoting weight loss, and minimizing adverse effects. Among these, tirzepatide a novel once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) re
1 Reached
Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes
Resistant Thyrotoxicosis in Pregnancy
1336 Reached4 Comments2 Likes
Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments
Short-term Insulin Therapy for better Glycemic Control
14 Reached5 Comments6 Likes